Correlation Between ESSA Pharma and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ESSA Pharma and Verrica Pharmaceuticals, you can compare the effects of market volatilities on ESSA Pharma and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and Verrica Pharmaceuticals.
Diversification Opportunities for ESSA Pharma and Verrica Pharmaceuticals
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ESSA and Verrica is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between ESSA Pharma and Verrica Pharmaceuticals
Given the investment horizon of 90 days ESSA Pharma is expected to generate 0.18 times more return on investment than Verrica Pharmaceuticals. However, ESSA Pharma is 5.59 times less risky than Verrica Pharmaceuticals. It trades about -0.46 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest 180.00 in ESSA Pharma on September 25, 2024 and sell it today you would lose (19.00) from holding ESSA Pharma or give up 10.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
ESSA Pharma vs. Verrica Pharmaceuticals
Performance |
Timeline |
ESSA Pharma |
Verrica Pharmaceuticals |
ESSA Pharma and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ESSA Pharma and Verrica Pharmaceuticals
The main advantage of trading using opposite ESSA Pharma and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.ESSA Pharma vs. Altamira Therapeutics | ESSA Pharma vs. Summit Therapeutics PLC | ESSA Pharma vs. Avenue Therapeutics | ESSA Pharma vs. Spero Therapeutics |
Verrica Pharmaceuticals vs. Oric Pharmaceuticals | Verrica Pharmaceuticals vs. Lyra Therapeutics | Verrica Pharmaceuticals vs. Inhibrx | Verrica Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |